TrialInvestigational new drugs2025

Orelabrutinib combined with rituximab and high-dose methotrexate as induction therapy in newly diagnosed primary central nervous system lymphoma.

Xi-Bin Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.